aod9604 vs frag 176 191 HGH Fragment 176-191: Dosage, Results & Side Effects (2026) AOD-9604 (HGH Fragment 176-191) —
Description
Studies using beta-3 adrenergic receptor knockout mice confirmed the specificity of this mechanism, as these animals showed no fat loss response to AOD-9604
Vitamin B12 or folate deficiency anaemia Causes

We designated these subclusters as doublets 1 and doublets 2, respectively, and excluded them from subsequent analyses involving the myogenic subset

(NCD-RisC)
Obes Res

What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
